Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CCI vs GSK✓SelectedUSD · GSKCCI vs GSK performance historyLatest closeAs of-0.26%11/18
Stock and ETF performance explorer

CCI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+50.9%
GSK return
+101.2%
Excess return
-50.3%
Maximum drawdown
-59.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.3%-1.3%+1.1%+0.2%
7D-5.7%-3.1%-2.6%-4.6%
30D+3.6%-0.9%+4.4%+3.9%
3M+15.0%-4.2%+19.2%+16.7%
6M-4.2%-1.6%-2.6%-4.0%
YTD-1.8%+2.6%-4.4%-4.1%
1Y-3.1%+6.2%-9.3%-6.6%
3Y-5.1%+55.0%-60.0%-24.1%
5Y-41.3%+42.8%-84.2%-52.4%
10Y+50.9%+102.1%-51.2%+5.1%
All+50.9%+101.2%-50.3%+5.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling